Task order b-1, animal model development and efficacy testing of candidate mcms

Active Awarded Last action

Contract number
75N93020F00002
Awardee
Awarding agency
Obligated
$14,486,445

Award facts

Opportunity
Contract value 100% obligated
$14,486,445.00 Current and potential, with all options
Completion date 97% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00015 $0
Change Order P00014 $1,057,669
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Change Order P00009 $1,506,692
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $3,307,379
Original award $8,614,705
Show all 16

About this award

Written by GovTribe AI ·

Task Order B-1 was awarded to Sri International on July 1, 2020, under a cost-plus-fixed-fee delivery order valued at $14.5 million with a completion date of December 30, 2026. The task order, titled "Animal Model Development and Efficacy Testing of Candidate MCMs" (Medical Countermeasures), was funded by the National Institute of Allergy and Infectious Diseases (NIAID) and performed in Menlo Park, California. The award was not set aside for small businesses and represents work conducted under Sri International's existing federal contract vehicles with NIAID. Sri International, a nonprofit research and development organization formerly known as Stanford Research Institute, leveraged its multidisciplinary scientific and technical capabilities to execute this complex biomedical research initiative focused on developing animal models and evaluating the efficacy of candidate medical countermeasures.

The task order engaged five subcontractors to support specialized research functions critical to the animal model development and efficacy testing mission. The Jackson Laboratory provided genetically engineered mouse models and animal husbandry services, while Charles River Laboratories Montreal ULC supplied non-human primate samples for biomarker discovery research in irradiated rhesus monkeys. Experimental Pathology Laboratories, Inc. contributed pathology and cytology services across multiple subcontract awards, and Metabolon, Inc. performed advanced metabolomic analysis of biological samples. These subcontractors collectively provided essential technical expertise in animal model development, sample collection, laboratory analysis, and pathological evaluation, enabling NIAID to advance its infectious disease research and medical countermeasure development priorities.

Quick answers

Who was awarded contract 75N93020F00002?

75N93020F00002 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.

How much is contract 75N93020F00002 worth?

The government has obligated $14,486,445 on 75N93020F00002.

Is contract 75N93020F00002 an order under another contract?

Yes. 75N93020F00002 is a delivery order under 75N93020D00011, an indefinite delivery contract.

Was contract 75N93020F00002 competed?

The extent of competition for 75N93020F00002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login